Sellas Life Sciences Group Inc (SLS)

Sellas Life Sciences Group Inc Azioni (SLS) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	0.079	-	-	-	-
Cost Of Revenue	-	-	-	-	-
Operating Expenses	9.724	-	-	-	-
Benefits Costs and Expenses	9.645	-	-	-	-
Costs And Expenses	17.95% 9.645	8.177	9.361	9.05	11.28
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	17.95% -9.645	-8.177	-9.361	-9.05	-11.28
Net Interest Income/Expense	92.68% 0.079	0.041	0.094	0.208	0.182
Nonoperating Income/Loss	92.68% 0.079	0.041	0.094	0.21	0.184
Income/Loss From Continuing Operations Before Tax	25.08% -9.566	-7.648	-9.361	-9.05	-11.28
Income/Loss From Continuing Operations After Tax	17.58% -9.566	-8.136	-9.267	-8.84	-11.10
Net Income/Loss	17.58% -9.566	-8.136	-9.267	-8.84	-11.10
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4,340% 44.81	1.0092	28.36	28.35	23.55
Diluted Average Shares	4,340% 44.81	1.0092	28.36	28.35	23.55
Basic Earnings Per Share	16.00% -0.21	-0.25	-0.33	-0.31	-0.47
Diluted Earnings Per Share	16.00% -0.21	-0.25	-0.33	-0.31	-0.47
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-